SCHEMBL29254453

SCHEMBL29254453

COc1cccc2c1ncc1c(I)n[nH]c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATP4A P20648 4/20 0.41
▸ ATP4B P51164 4/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ HTR1A P08908 2/20 0.40
▸ ADRA1D P25100 2/20 0.40
▸ ADRA1A P35348 2/20 0.40
▸ ADRA1B P35368 2/20 0.40
▸ ABL1 P00519 1/20 0.40
▸ RAD52 P43351 1/20 0.40
▸ RIN1 Q13671 1/20 0.40
▸ GABRP O00591 1/20 0.40
▸ GABRD O14764 1/20 0.40
▸ GABRA1 P14867 1/20 0.40
▸ GABRB1 P18505 1/20 0.40
▸ GABRG2 P18507 1/20 0.40
▸ GABRB3 P28472 1/20 0.40
▸ GABRA5 P31644 1/20 0.40
▸ GABRA3 P34903 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5484683 0.80 KDM4E (0.53) KDM4EALDH1A1HPGDABL1RAD52
SCHEMBL30039348 0.80 KDM4E (0.53) KDM4EALDH1A1HPGDABL1RAD52
SCHEMBL29254461 0.78 PDE4A (0.54) KDM4EALDH1A1HPGDSTNFLITAF
SCHEMBL30951512 0.78 PDE4A (0.54) KDM4EALDH1A1HPGDSTNFLITAF
SCHEMBL30345130 0.74 ALDH1A1 (0.54) ATP4AATP4BKDM4EALDH1A1HPGD
SCHEMBL29254424 0.74 ALDH1A1 (0.54) ATP4AATP4BKDM4EALDH1A1HPGD
SCHEMBL594346 0.72 KDM4E (0.55) KDM4EALDH1A1HPGDABL1RAD52
SCHEMBL20813844 0.72 HTR1A (0.49) ATP4AATP4BHPGDHTR1AADRA1D
SCHEMBL29254423 0.70 KDM4E (0.41) KDM4EGABRPGABRDGABRA1GABRB1
SCHEMBL8130885 0.70 KDM4E (0.48) ATP4AATP4BKDM4EALDH1A1HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250011319-A1 SUBSTITUTED 1H-PYRAZOLO [4,3-c] QUINOLINES, METHODS OF PREPARATION, AND USE THEREOF LOMOND THERAPEUTICS, INC. 2025-01-09 — — US claimed
CN-118076605-A Substituted 1H-pyrazolo [4,3-c ] quinolines, methods of preparation and uses thereof 洛蒙治疗公司 2024-05-24 — — CN claimed
US-20250011319-A1 SUBSTITUTED 1H-PYRAZOLO [4,3-c] QUINOLINES, METHODS OF PREPARATION, AND USE THEREOF LOMOND THERAPEUTICS, INC. 2025-01-09 — — US disclosed
CN-118076605-A Substituted 1H-pyrazolo [4,3-c ] quinolines, methods of preparation and uses thereof 洛蒙治疗公司 2024-05-24 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250011319-A1 SUBSTITUTED 1H-PYRAZOLO [4,3-c] QUINOLINES, METHODS OF PREPARATION, AND USE THEREOF FLT3, PDXK, PHKG1 ATP4A 1798/4885ATP4B 3587/4885KDM4E 2039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback